Virta Health

GLP-1s and insulin are commonly prescribed to treat obesity and type 2 diabetes. But as costs climb, health plan and benefits leaders are asking: Do members need to stay on medications for life? And when is deprescription clinically appropriate? Join Virta for a candid conversation about how member-centered, evidence-based care can reduce or even eliminate reliance on costly medications that may no longer be needed or well tolerated. Hear three points of view on the value stepping down safely brings to members and the bottom line.

Three years strong—and thousands of lives changed. We’re proud to partner with Banner|Aetna on a shared mission: not just to manage type 2 diabetes, but to reverse it. This is what happens when a health plan leads with innovation and puts members first. 💙

The evidence is clear: nutrition and lifestyle changes are essential—whether or not GLP-1s are taken for weight loss. Thank you to Hinge Health for spotlighting our CCO, Laura (Gilligan) Walmsley and the role of nutrition-first, clinically guided care in driving long-term outcomes. And thanks to Vikki Walton, Mercer, and Jeff Stanley MD for sharing your insights!

Big moment for Virta! Our CEO, Sami, represented Virta at the White House, where the administration launched a new Health Tech Ecosystem Initiative—focused on expanding digital health access with a spotlight on consumer impact. What this means: Virta’s model was highlighted as part of the future of accessible, outcomes-driven care. We were named one of the “60 most important health companies” in the room—a powerful signal as we scale our care to Millions of members and work to reach the 150M+ Americans who could benefit from better metabolic health. This wasn’t just visibility—it was recognition. We’re building trusted partnerships with Medicare, the VA, and major employers, and moments like this are critical to expanding our reach and impact. We’re here to change the narrative around metabolic health—with real outcomes and science-backed support. Let’s keep going. This moment matters. #VirtaHealth #MetabolicHealth #DiabetesReversal #DigitalHealth #HealthTech #HealthcareInnovation

“𝘼𝙄 𝙞𝙨 𝙖 𝙛𝙤𝙧𝙘𝙚 𝙢𝙪𝙡𝙩𝙞𝙥𝙡𝙞𝙚𝙧 𝙛𝙤𝙧 𝙘𝙡𝙖𝙧𝙞𝙩𝙮 𝙖𝙣𝙙 𝙤𝙪𝙩𝙥𝙪𝙩.” – Sami Inkinen, CEO of Virta Health In a recent Fast Company feature, Sami shared how AI is reshaping the way he leads—helping him synthesize market signals, explore strategic scenarios, and make high-impact decisions faster. At Virta, we’re not just using AI to speed things up—we’re using it to think more clearly, act more decisively, and stay focused on what matters most: 𝘁𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺𝗶𝗻𝗴 𝗹𝗶𝘃𝗲𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗯𝗲𝘁𝘁𝗲𝗿 𝗺𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵. Read the full article to learn how leaders across industries are putting AI to work—strategically, ethically, and effectively. 🔗 https://bit.ly/45py1Sc #VirtaHealth #AILeadership #MetabolicHealth #FutureOfWork #HealthTech #DigitalHealth #Innovation

𝗧𝗵𝗲 𝘀𝗲𝗺𝗮𝗴𝗹𝘂𝘁𝗶𝗱𝗲 𝘀𝗵𝗼𝗿𝘁𝗮𝗴𝗲 𝗶𝘀 𝗼𝘃𝗲𝗿. 𝗕𝘂𝘁 𝘁𝗵𝗲 𝗰𝗼𝗻𝗳𝘂𝘀𝗶𝗼𝗻 𝗮𝗿𝗼𝘂𝗻𝗱 𝗰𝗼𝗺𝗽𝗼𝘂𝗻𝗱𝗲𝗱 𝗚𝗟𝗣-𝟭𝘀 𝗶𝘀𝗻’𝘁. During the shortage, millions turned to compounded versions of Ozempic or Wegovy. Now that the FDA has ended its temporary allowance, many are left wondering what comes next. Dr. Jeff Stanley MD, Medical Director at Virta, puts it simply: “FDA-approved GLP-1s are much safer than compounded alternatives.” But switching isn’t always straightforward. • Doses may not match • Ingredients can vary • Side effects can increase without guidance 𝗩𝗶𝗿𝘁𝗮 𝗺𝗮𝗸𝗲𝘀 𝘁𝗵𝗲 𝘀𝘄𝗶𝘁𝗰𝗵 𝘀𝗮𝗳𝗲𝗿. Our clinical team helps patients transition with confidence—minimizing risks, monitoring outcomes, and supporting long-term success. 𝗧𝗵𝗶𝘀 𝗶𝘀 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗰𝗮𝗿𝗲: science-backed, patient-first, and results-driven. Learn more: https://bit.ly/4kTh3jz #VirtaHealth #GLP1 #Semaglutide #MetabolicHealth #Type2Diabetes

𝗪𝗮𝗻𝘁 𝘁𝗼 𝗮𝘁𝘁𝗲𝗻𝗱 The Conference Board 𝗛𝗲𝗮𝗹𝘁𝗵 & 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗶𝘁𝘆 𝗙𝗼𝗿𝘂𝗺 𝗶𝗻 𝗖𝗵𝗶𝗰𝗮𝗴𝗼 (𝗢𝗰𝘁 𝟭𝟲–𝟭𝟳) 𝗯𝘂𝘁 𝘀𝗵𝗼𝗿𝘁 𝗼𝗻 𝗯𝘂𝗱𝗴𝗲𝘁? Virta’s got you covered — we’re offering a limited number of 𝗰𝗼𝗺𝗽𝗹𝗶𝗺𝗲𝗻𝘁𝗮𝗿𝘆 𝗽𝗮𝘀𝘀𝗲𝘀 to support folks driving real impact in workplace health. 🎟️ Claim yours here: https://bit.ly/4m1MJEG Tag someone who should be there 👇

🚨 𝟭 𝗶𝗻 𝟯 𝗨.𝗦. 𝘁𝗲𝗲𝗻𝘀 𝗻𝗼𝘄 𝗵𝗮𝘀 𝗽𝗿𝗲𝗱𝗶𝗮𝗯𝗲𝘁𝗲𝘀. That’s the latest estimate from the CDC — 𝗻𝗲𝗮𝗿𝗹𝘆 𝟴.𝟰 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗮𝗱𝗼𝗹𝗲𝘀𝗰𝗲𝗻𝘁𝘀 between ages 12–17. Just a few years ago, that number was closer to 1 in 5. The data signals a growing crisis in youth metabolic health. And while the CDC’s updated methodology has raised some questions among experts, the overall trend is clear: ➡️ More kids are developing early signs of insulin resistance. ➡️ We’re not doing enough to prevent it. Prediabetes increases the risk of type 2 diabetes, heart disease, and other long-term health issues. It's a wake-up call for parents, schools, and healthcare providers. ✅ Screen early (age 10+) ✅ Support a lower-carb, whole-food approach ✅ Shift the narrative from blame to action This isn’t just about data. It’s about our future. 𝗔𝘁 𝗩𝗶𝗿𝘁𝗮, 𝘄𝗲’𝗿𝗲 𝘄𝗼𝗿𝗸𝗶𝗻𝗴 𝘁𝗼 𝗰𝗵𝗮𝗻𝗴𝗲 𝘁𝗵𝗶𝘀 𝘀𝘁𝗼𝗿𝘆 — 𝗳𝗼𝗿 𝗮𝗱𝘂𝗹𝘁𝘀 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗻𝗲𝘅𝘁 𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻. 💙 Source linked in the comments ⬇️ #VirtaHealth #MetabolicHealth #YouthDiabetes #Prediabetes #InsulinResistance #BloodSugarMatters #Type2Diabetes

Behind every number is a person. A life changed. A family healed. A future regained. We’ve helped over 100,000 people reverse type 2 diabetes. But millions more still need this care. We won’t stop until reversal—not just management—is the new standard. #VirtaHealth #ChronicCare #HealthcareInnovation #DiabetesReversal #ReversalNotManagement

Welcome to Laura (Gilligan) Walmsley as our new Chief Commercial Officer!🎉 Laura arrives with 25+ years of powerhouse experience scaling healthcare organizations—most recently guiding triple-digit growth at Personify Health. She’ll steer Virta’s commercial strategy and all client-facing teams as we: • Support 550+ employers & health plans (12 M covered lives) • Accelerate past $100 M+ annualized revenue with >80% YoY growth • Enroll more new members in 2025 than our first 10 years combined Demand for nutrition-first diabetes reversal and sustainable weight loss is soaring, and Laura’s leadership will help us meet it—fast. Join us in giving her a warm Virta welcome as we charge toward our mission of reversing diabetes and obesity in one billion people. 💙 https://yhoo.it/3Tfj52n #VirtaHealth #Leadership #Growth #DiabetesReversal #WeightLoss #HealthcareInnovation